Detalle Publicación


Oncogenic activity of SOX1 in glioblastoma

Autores: Garcia, I. ; Aldaregia, J. ; Vicentic, J. M.; Aldaz, P.; Moreno Cugnon, L. ; Torres Bayona, S. ; Carrasco Garcia, E. ; Garros Regulez, L.; Egana, L.; Rubio Díaz-Cordoves, Ángel; Pollard, S.; Stevanovic, M. ; Sampron, N.; Matheu, A.
Título de la revista: SCIENTIFIC REPORTS
ISSN: 2045-2322
Volumen: 7
Fecha de publicación: 2017
Glioblastoma remains the most common and deadliest type of brain tumor and contains a population of self-renewing, highly tumorigenic glioma stem cells (GSCs), which contributes to tumor initiation and treatment resistance. Developmental programs participating in tissue development and homeostasis re-emerge in GSCs, supporting the development and progression of glioblastoma. SOX1 plays an important role in neural development and neural progenitor pool maintenance. Its impact on glioblastoma remains largely unknown. In this study, we have found that high levels of SOX1 observed in a subset of patients correlate with lower overall survival. At the cellular level, SOX1 expression is elevated in patient-derived GSCs and it is also higher in oncosphere culture compared to differentiation conditions in conventional glioblastoma cell lines. Moreover, genetic inhibition of SOX1 in patient-derived GSCs and conventional cell lines decreases self-renewal and proliferative capacity in vitro and tumor initiation and growth in vivo. Contrarily, SOX1 over-expression moderately promotes self-renewal and proliferation in GSCs. These functions seem to be independent of its activity as Wnt/beta-catenin signaling regulator. In summary, these results identify a functional role for SOX1 in regulating glioma cell heterogeneity and plasticity, and suggest SOX1 as a potential target in the GSC population in glioblastoma.